285 related articles for article (PubMed ID: 22363701)
1. CD200 positive human mesenchymal stem cells suppress TNF-alpha secretion from CD200 receptor positive macrophage-like cells.
Pietilä M; Lehtonen S; Tuovinen E; Lähteenmäki K; Laitinen S; Leskelä HV; Nätynki A; Pesälä J; Nordström K; Lehenkari P
PLoS One; 2012; 7(2):e31671. PubMed ID: 22363701
[TBL] [Abstract][Full Text] [Related]
2. Diminution of Phagocytosed Micro/Nanoparticles by Tethering with Immunoregulatory CD200 Protein.
Zhang J; Peng CA
Sci Rep; 2020 May; 10(1):8604. PubMed ID: 32451434
[TBL] [Abstract][Full Text] [Related]
3. CD200R/CD200 inhibits osteoclastogenesis: new mechanism of osteoclast control by mesenchymal stem cells in human.
Varin A; Pontikoglou C; Labat E; Deschaseaux F; Sensebé L
PLoS One; 2013; 8(8):e72831. PubMed ID: 23940819
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis.
Copland DA; Calder CJ; Raveney BJ; Nicholson LB; Phillips J; Cherwinski H; Jenmalm M; Sedgwick JD; Dick AD
Am J Pathol; 2007 Aug; 171(2):580-8. PubMed ID: 17600119
[TBL] [Abstract][Full Text] [Related]
5. Preconditioning of bone marrow-derived mesenchymal stem cells highly strengthens their potential to promote IL-6-dependent M2b polarization.
Philipp D; Suhr L; Wahlers T; Choi YH; Paunel-Görgülü A
Stem Cell Res Ther; 2018 Oct; 9(1):286. PubMed ID: 30359316
[TBL] [Abstract][Full Text] [Related]
6. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially.
Prasanna SJ; Gopalakrishnan D; Shankar SR; Vasandan AB
PLoS One; 2010 Feb; 5(2):e9016. PubMed ID: 20126406
[TBL] [Abstract][Full Text] [Related]
7. [CD200/CD200R Expression Levels and Its Significance after Allogeneic Hematopoietic Stem Cell Transplantation].
Huang YH; Zhang W; Cai H; Li TJ; Li J; Han B; Zhuang JL; Zhu TN; Cai HC; Zhou DB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):815-20. PubMed ID: 27342516
[TBL] [Abstract][Full Text] [Related]
8. [Regulatory effect of bone marrow mesenchymal stem cells on polarization of macrophages].
Hou Y; Zhou X; Cai WL; Guo CC; Han Y
Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):273-278. PubMed ID: 28494546
[No Abstract] [Full Text] [Related]
9. Upregulation of CD200 is associated with Foxp3+ regulatory T cell expansion and disease progression in acute myeloid leukemia.
Memarian A; Nourizadeh M; Masoumi F; Tabrizi M; Emami AH; Alimoghaddam K; Hadjati J; Mirahmadian M; Jeddi-Tehrani M
Tumour Biol; 2013 Feb; 34(1):531-42. PubMed ID: 23179394
[TBL] [Abstract][Full Text] [Related]
10. Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes.
Najar M; Raicevic G; Jebbawi F; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Immunol Lett; 2012 Aug; 146(1-2):50-6. PubMed ID: 22575528
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages.
Kim J; Hematti P
Exp Hematol; 2009 Dec; 37(12):1445-53. PubMed ID: 19772890
[TBL] [Abstract][Full Text] [Related]
12. Characterization of clonally derived, spontaneously transformed bone marrow macrophage cell lines from lipopolysaccharide hyporesponsive LPS(d) and normal LPS(n) mice.
Monner DA; Denker B
J Leukoc Biol; 1997 Apr; 61(4):469-80. PubMed ID: 9103234
[TBL] [Abstract][Full Text] [Related]
13. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile.
Maggini J; Mirkin G; Bognanni I; Holmberg J; Piazzón IM; Nepomnaschy I; Costa H; Cañones C; Raiden S; Vermeulen M; Geffner JR
PLoS One; 2010 Feb; 5(2):e9252. PubMed ID: 20169081
[TBL] [Abstract][Full Text] [Related]
14. The CD200 Regulates Inflammation in Mice Independently of TNF-α Production.
Tonecka K; Braniewska A; Pilch Z; Sas Z; Skorzynski M; Manuali E; Rygiel TP
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069671
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation.
Walker DG; Dalsing-Hernandez JE; Campbell NA; Lue LF
Exp Neurol; 2009 Jan; 215(1):5-19. PubMed ID: 18938162
[TBL] [Abstract][Full Text] [Related]
16. Regulation of myeloid cell function through the CD200 receptor.
Jenmalm MC; Cherwinski H; Bowman EP; Phillips JH; Sedgwick JD
J Immunol; 2006 Jan; 176(1):191-9. PubMed ID: 16365410
[TBL] [Abstract][Full Text] [Related]
17. The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma.
Stumpfova M; Ratner D; Desciak EB; Eliezri YD; Owens DM
Cancer Res; 2010 Apr; 70(7):2962-72. PubMed ID: 20332223
[TBL] [Abstract][Full Text] [Related]
18. Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells.
Mihrshahi R; Barclay AN; Brown MH
J Immunol; 2009 Oct; 183(8):4879-86. PubMed ID: 19786546
[TBL] [Abstract][Full Text] [Related]
19. Local targeting of the CD200-CD200R axis does not promote corneal graft survival.
Nicholls SM; Copland DA; Vitova A; Kuffova L; Forrester JV; Dick AD
Exp Eye Res; 2015 Jan; 130():1-8. PubMed ID: 25450061
[TBL] [Abstract][Full Text] [Related]
20. Preconditioning of murine mesenchymal stem cells synergistically enhanced immunomodulation and osteogenesis.
Lin T; Pajarinen J; Nabeshima A; Lu L; Nathan K; Jämsen E; Yao Z; Goodman SB
Stem Cell Res Ther; 2017 Dec; 8(1):277. PubMed ID: 29212557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
